Development, is also participating in today's call. Following our prepared remarks, we will open the call for Q&A. Now I would like to turn the call over to Ofer Gonen, Chief Executive Officer of ...

The Liberals’ newcomer apocalypse has finally turned into their worst political problem. Hospitals are overburdened, schools ...

Claude Cowork lets AI analyze files, browse the web, and run business tasks autonomously. Allie K. Miller explains exactly ...

Cash-based Q4 operating expenses -- $11.9 million, up $900,000 sequentially from Q3, primarily due to the addition of the ...

Increased 40%, with 20% organic growth, supported by higher sales of contactless cards and strong instant issuance performance. Adjusted EBITDA -- Increased 34% to $29.4 million in the quarter; margin ...

Thank you, and thank you all for joining us on today's conference call to discuss EyePoint Pharmaceuticals, Inc.'s Fourth Quarter and Full Year 2025 financial results and recent corporate developments ...

The only approved gene therapy for RP today targets a single gene RPE65, which accounts for just 1% to 2% of the total RP patient population. We believe OCU400 has significantly wider commercial ...

Q4 2025 Earnings Call March 4, 2026 5:00 PM ESTCompany ParticipantsMonica GouldSanjeev Aggarwal - President, CEO ...

AI recommendations are decided upstream. Understand the 10-gate pipeline, where brands fail, and how small improvements compound.

Alkami Technology, Inc. ("Alkami"), a digital sales and service platform provider for financial institutions in the U.S., today announced a major enhancement to its Software Development Kit (SDK) with ...

Aspen Aerogels, Inc. (NYSE:ASPN) Q4 2025 Earnings Call Transcript February 25, 2026 Aspen Aerogels, Inc. misses on earnings ...

Verisk Analytics, Inc. (NASDAQ:VRSK) Q4 2025 Earnings Call Transcript February 18, 2026 Verisk Analytics, Inc. misses on earnings expectations. Reported EPS is $1.42 EPS, expectations were $1.6.